This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Al-Madhoun A.S., Johnsamuel J., Barth R.F., Tjarks W., Eriksson S.: Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy. Cancer Res., 2004; 64: 6280–6286Al-MadhounA.S.JohnsamuelJ.BarthR.F.TjarksW.ErikssonS.Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy2004646280628610.1158/0008-5472.CAN-04-0197Search in Google Scholar
Archambeau J.O.: The effect of increasing exposures of the 10B(n,α)7Li reaction on the skin of man. Radiology, 1970; 94: 178–187ArchambeauJ.O.The effect of increasing exposures of the 10B(n,α)7Li reaction on the skin of man197094178187Search in Google Scholar
Barth R.F., Coderre J.A., Vicente M.G., Blue T.E.: Boron neutron capture therapy of cancer: Current status and future prospects. Clin. Cancer. Res., 2005; 11: 3987–4002BarthR.F.CoderreJ.A.VicenteM.G.BlueT.E.Boron neutron capture therapy of cancer: Current status and future prospects2005113987400210.1158/1078-0432.CCR-05-0035Search in Google Scholar
Barth R.F., Kabalka G.W., Yang W., Huo T., Nakkula R.J., Shaikh A.L., Haider S.A., Chandra S.: Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomas. Appl. Radiat. Isot., 2014; 88: 38–42BarthR.F.KabalkaG.W.YangW.HuoT.NakkulaR.J.ShaikhA.L.HaiderS.A.ChandraS.Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomas201488384210.1016/j.apradiso.2013.11.133Search in Google Scholar
Barth R.F., Mi P., Yang W.: Boron delivery agents for neutron capture therapy of cancer. Cancer Commun., 2018; 38: 35BarthR.F.MiP.YangW.Boron delivery agents for neutron capture therapy of cancer2018383510.1186/s40880-018-0299-7Search in Google Scholar
Barth R.F., Yang W., Nakkula R.J., Byun Y., Tjarks W., Wu L.C., Binns P.J., Riley K.J.: Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors. Appl. Radiat. Isot., 2015; 106: 251–255BarthR.F.YangW.NakkulaR.J.ByunY.TjarksW.WuL.C.BinnsP.J.RileyK.J.Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors201510625125510.1016/j.apradiso.2015.06.031Search in Google Scholar
Barth R.F., Yang W., Rotaru J.H., Moeschberger M.L., Joel D.D., Nawrocky M.M., Goodman J.H., Soloway A.H..: Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood–brain barrier disruption. Cancer Res., 1997; 57: 1129–1136BarthR.F.YangW.RotaruJ.H.MoeschbergerM.L.JoelD.D.NawrockyM.M.GoodmanJ.H.SolowayA.H.Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood–brain barrier disruption1997571129113610.1016/S0360-3016(00)00421-1Search in Google Scholar
Bertrand N., Wu J., Xu X., Kamaly N., Farokhzad O.C.: Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev. 2014; 66: 2–25BertrandN.WuJ.XuX.KamalyN.FarokhzadO.C.Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology20146622510.1016/j.addr.2013.11.009421925424270007Search in Google Scholar
Bhimanapati G.R., Glavin N.R. Robinson J.A.: 2D boron nitride: Synthesis and applications. Semicond. Semimet., 2016; 95: 101–147BhimanapatiG.R.GlavinN.R.RobinsonJ.A.2D boron nitride: Synthesis and applications20169510114710.1016/bs.semsem.2016.04.004Search in Google Scholar
Bortolussi S., Bakeine J.G., Ballarini F., Bruschi P., Gadan M. A., Protti N., Stella S., Clerici A., Ferrari C., Cansolino L., Zonta C., Zonta A., Nano R., Altieri S.: Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours. Appl. Radiat. Isot., 2011; 69: 394–398BortolussiS.BakeineJ.G.BallariniF.BruschiP.GadanM. A.ProttiN.StellaS.ClericiA.FerrariC.CansolinoL.ZontaC.ZontaA.NanoR.AltieriS.Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours20116939439810.1016/j.apradiso.2010.11.01821145752Search in Google Scholar
Capuani S., Gili T., Bozzali M., Russo S., Porcari P., Cametti C., Muolo M., D’Amore E., Maraviglia B., Lazzarino G., Pastore F.S.: Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading. Appl. Radiat. Isot., 2009; 67: S34–S36CapuaniS.GiliT.BozzaliM.RussoS.PorcariP.CamettiC.MuoloM.D’AmoreE.MaravigliaB.LazzarinoG.PastoreF.S.Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading200967S34S3610.1016/j.apradiso.2009.03.01719375337Search in Google Scholar
Chen X., Wu P., Rousseas M., Okawa D., Gartner Z., Zettl A., Bertozzi C.R.: Boron nitride nanotubes are noncytotoxic and can be functionalized for interaction with proteins and cells. J. Am. Chem. Soc., 2009; 131: 890–891ChenX.WuP.RousseasM.OkawaD.GartnerZ.ZettlA.BertozziC.R.Boron nitride nanotubes are noncytotoxic and can be functionalized for interaction with proteins and cells200913189089110.1021/ja807334b265703819119844Search in Google Scholar
Ciofani G., Danti S., D’Alessandro D., Moscato S., Menciassi A.: Assessing cytotoxicity of boron nitride nanotubes: Interference with the MTT assay. Biochem. Biophys. Res. Commun., 2010; 394: 405–411CiofaniG.DantiS.D’AlessandroD.MoscatoS.MenciassiA.Assessing cytotoxicity of boron nitride nanotubes: Interference with the MTT assay201039440541110.1016/j.bbrc.2010.03.03520226164Search in Google Scholar
Ciofani G., Danti S., Genchi G.G., Mazzolai B., Mattoli V.: Boron nitride nanotubes: Biocompatibility and potential spill-over in nanomedicine. Small., 2013; 9: 1672–1685CiofaniG.DantiS.GenchiG.G.MazzolaiB.MattoliV.Boron nitride nanotubes: Biocompatibility and potential spill-over in nanomedicine201391672168510.1002/smll.20120131523423826Search in Google Scholar
Ciofani G., Raffa V., Menciassi., Cuschieri A.: Cytocompatibility, interactions, and uptake of polyethyleneimine-coated boron nitride nanotubes by living cells: Confirmation of their potential for biomedical applications. Biotechnol. Bioeng., 2008; 101: 850–858CiofaniG.RaffaV.Menciassi.CuschieriA.Cytocompatibility, interactions, and uptake of polyethyleneimine-coated boron nitride nanotubes by living cells: Confirmation of their potential for biomedical applications200810185085810.1002/bit.2195218512259Search in Google Scholar
Coderre J.A., Glass J.D., Fairchild R.G., Micca P.L., Fand I., Joel D.D.: Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma. Cancer Res., 1990; 50: 138–141CoderreJ.A.GlassJ.D.FairchildR.G.MiccaP.L.FandI.JoelD.D.Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma199050138141Search in Google Scholar
Cui D., Tian F., Ozkan C.S., Wang M., Gao H.: Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol. Lett., 2005; 155: 73–85CuiD.TianF.OzkanC.S.WangM.GaoH.Effect of single wall carbon nanotubes on human HEK293 cells2005155738510.1016/j.toxlet.2004.08.01515585362Search in Google Scholar
Dahlström M., Capala J., Lindström P., Wasteson Å., Lindström A.: Accumulation of boron in human malignant glioma cells in vitro is cell type dependent. J. Neuro-Oncol., 2004; 68: 199–205DahlströmM.CapalaJ.LindströmP.WastesonÅ.LindströmA.Accumulation of boron in human malignant glioma cells in vitro is cell type dependent20046819920510.1023/B:NEON.0000033489.54011.6bSearch in Google Scholar
Dobrzyński L.: Spowalnianie neutronów w moderatorze. W: Podstawy Fizyki Reaktorów Jądrowych, red.: L. Dobrzyński. Świerk 2013, 60–61DobrzyńskiL.Spowalnianie neutronów w moderatorzeW:red.:DobrzyńskiL.Świerk20136061Search in Google Scholar
Duong N.M., Glushkov E., Chernev A., Navikas V., Comtet J., Nguyen M.A., Toth M., Radenovic A., Tran T.T., Aharonovich I.: Facile production of hexagonal boron nitride nanoparticles by cryogenic exfoliation. Nano. Lett., 2019: 19: 5417–5422DuongN.M.GlushkovE.ChernevA.NavikasV.ComtetJ.NguyenM.A.TothM.RadenovicA.TranT.T.AharonovichI.Facile production of hexagonal boron nitride nanoparticles by cryogenic exfoliation2019195417542210.1021/acs.nanolett.9b0191331264881Search in Google Scholar
Feng B., Tomizawa K., Michiue H., Miyatake S., Han X.J., Fujimura A., Seno M., Kirihata M., Matsui H.: Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His. Biomaterials, 2009; 30: 1746–1755FengB.TomizawaK.MichiueH.MiyatakeS.HanX.J.FujimuraA.SenoM.KirihataM.MatsuiH.Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His2009301746175510.1016/j.biomaterials.2008.12.01019121537Search in Google Scholar
Ferreira T.H., Miranda M.C., Rocha Z., Leal A.S., Gomes D.A., Sousa E.M.: An assessment of the potential use of BNNTs for Boron Neutron Capture Therapy. Nanomaterials, 2017; 7: 82FerreiraT.H.MirandaM.C.RochaZ.LealA.S.GomesD.A.SousaE.M.An assessment of the potential use of BNNTs for Boron Neutron Capture Therapy201778210.3390/nano7040082540817428417903Search in Google Scholar
Gao Z., Horiguchi Y., Nakai K., Matsumura A., Suzuki M., Ono K., Nagasaki Y:. Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects. Biomaterials, 2016; 104: 201–212GaoZ.HoriguchiY.NakaiK.MatsumuraA.SuzukiM.OnoK.NagasakiY.Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects201610420121210.1016/j.biomaterials.2016.06.04627467416Search in Google Scholar
Gonzalez-Ortiz D., Salameh C., Bechelany M., Miele P.: Nanostructured boron nitride – based materials: Synthesis and applications. Mater. Today Adv., 2020; 8: 100107Gonzalez-OrtizD.SalamehC.BechelanyM.MieleP.Nanostructured boron nitride – based materials: Synthesis and applications2020810010710.1016/j.mtadv.2020.100107Search in Google Scholar
Goodman J.H., Yang W., Barth R.F., Gao Z., Boesel C.P., Staubus A.E., Gupta N., Gahbauer R.A., Adams D.M., Gibson C.R., Ferketich A.K., Moeschberger M.L., Soloway A.H., Carpenter D.E., Albertson B.J. i wsp.: Boron neutron capture therapy of brain tumors: Biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas. Neurosurgery, 2000; 47: 608–621GoodmanJ.H.YangW.BarthR.F.GaoZ.BoeselC.P.StaubusA.E.GuptaN.GahbauerR.A.AdamsD.M.GibsonC.R.FerketichA.K.MoeschbergerM.L.SolowayA.H.CarpenterD.E.AlbertsonB.J.i wsp.Boron neutron capture therapy of brain tumors: Biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas200047608621Search in Google Scholar
Hatanaka H., Nakagawa Y.: Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys., 1994; 28: 1061–1066HatanakaH.NakagawaY.Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy1994281061106610.1016/0360-3016(94)90479-0Search in Google Scholar
Hiratsuka J., Kamitani N., Tanaka R., Tokiya R., Yoden E., Sakurai Y., Suzuki M.: Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT). J. Radiat. Res., 2020; 61: 945–951HiratsukaJ.KamitaniN.TanakaR.TokiyaR.YodenE.SakuraiY.SuzukiM.Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)20206194595110.1093/jrr/rraa068767469532990318Search in Google Scholar
Horváth L., Magrez A., Golberg D., Zhi C., Bando Y., Smajda R., Horváth E., Forró L., Schwaller B.: In vitro investigation of the cellular toxicity of boron nitride nanotubes. ACS Nano, 2011; 5: 3800–3810HorváthL.MagrezA.GolbergD.ZhiC.BandoY.SmajdaR.HorváthE.ForróL.SchwallerB.In vitro investigation of the cellular toxicity of boron nitride nanotubes201153800381010.1021/nn200139h21495683Search in Google Scholar
Ichikawa H., Taniguchi E., Fujimoto T., Fukumori Y.: Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer. Appl. Radiat. Isot., 2009; 67: S111–S114IchikawaH.TaniguchiE.FujimotoT.FukumoriY.Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer200967S111S11410.1016/j.apradiso.2009.03.02619376721Search in Google Scholar
Ishikawa Y., Shimizu Y., Sasaki T., Koshizaki N.: Boron carbide spherical particles encapsulated in graphite prepared by pulsed laser irradiation of boron in liquid medium. Appl. Phys. Lett., 2007; 91: 161110IshikawaY.ShimizuY.SasakiT.KoshizakiN.Boron carbide spherical particles encapsulated in graphite prepared by pulsed laser irradiation of boron in liquid medium20079116111010.1063/1.2799786Search in Google Scholar
Itoh T., Tamura K., Ueda H., Tanaka T., Sato K., Kuroda R., Aoki S.: Design and synthesis of boron containing monosaccharides by the hydroboration of D-glucal for use in boron neutron capture therapy (BNCT). Bioorg. Med. Chem., 2018; 26: 5922–5933ItohT.TamuraK.UedaH.TanakaT.SatoK.KurodaR.AokiS.Design and synthesis of boron containing monosaccharides by the hydroboration of D-glucal for use in boron neutron capture therapy (BNCT)2018265922593310.1016/j.bmc.2018.10.04130420329Search in Google Scholar
Iwagami T., Ishikawa Y., Koshizaki N., Yamamoto N., Tanaka H., Masunaga S., Sakurai Y., Kato I., Iwai S., Suzuki M., Yura Y.: Boron carbide particle as a boron compound for Boron Neutron Capture Therapy. J. Nucl. Med. Radiat. Ther., 2014; 5: 2IwagamiT.IshikawaY.KoshizakiN.YamamotoN.TanakaH.MasunagaS.SakuraiY.KatoI.IwaiS.SuzukiM.YuraY.Boron carbide particle as a boron compound for Boron Neutron Capture Therapy201452Search in Google Scholar
Kabalka G.W., Shaikh A.L., Barth R.F., Huo T., Yang W., Gordnier P.M., Chandra S.: Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapy. Appl. Radiat. Isot., 2011; 69: 1778–1781KabalkaG.W.ShaikhA.L.BarthR.F.HuoT.YangW.GordnierP.M.ChandraS.Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapy2011691778178110.1016/j.apradiso.2011.03.035313578321481596Search in Google Scholar
Kabalka G.W., Yao M.L., Marepally S.R., Chandra S.: Biological evaluation of boronated unnatural amino acids as new boron carriers. Appl. Radiat. Isot., 2009; 67: S374–S379KabalkaG.W.YaoM.L.MarepallyS.R.ChandraS.Biological evaluation of boronated unnatural amino acids as new boron carriers200967S374S37910.1016/j.apradiso.2009.03.104286133319398346Search in Google Scholar
Kageji T., Nagahiro S., Mizobuchi Y., Matsuzaki K., Nakagawa Y., Kumada H.: Boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma: Comparison of clinical results obtained with BNCT and conventional treatment. J. Med. Invest., 2014; 61: 254–263KagejiT.NagahiroS.MizobuchiY.MatsuzakiK.NakagawaY.KumadaH.Boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma: Comparison of clinical results obtained with BNCT and conventional treatment20146125426310.2152/jmi.61.25425264042Search in Google Scholar
Kato I., Fujita Y., Maruhashi A., Kumada H., Ohmae M., Kirihata M., Imahori Y., Suzuki M., Sakrai Y., Sumi T., Iwai S., Nakazawa M., Murata I., Miyamaru H., Ono K.: Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies. Appl. Radiat. Isot., 2009; 67: S37–S42KatoI.FujitaY.MaruhashiA.KumadaH.OhmaeM.KirihataM.ImahoriY.SuzukiM.SakraiY.SumiT.IwaiS.NakazawaM.MurataI.MiyamaruH.OnoK.Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies200967S37S4210.1016/j.apradiso.2009.03.10319409799Search in Google Scholar
Kato T., Hirose K., Tanaka H., Mitsumoto T., Motoyanagi T., Arai K., Harada T., Takeuchi A., Kato R., Yajima S., Takai Y.: Design and construction of an accelerator-based boron neutron capture therapy (AB-BNCT) facility with multiple treatment rooms at the Southern Tohoku BNCT Research Center. Appl. Radiat. Isot., 2020; 156: 108961KatoT.HiroseK.TanakaH.MitsumotoT.MotoyanagiT.AraiK.HaradaT.TakeuchiA.KatoR.YajimaS.TakaiY.Design and construction of an accelerator-based boron neutron capture therapy (AB-BNCT) facility with multiple treatment rooms at the Southern Tohoku BNCT Research Center202015610896110.1016/j.apradiso.2019.10896131683088Search in Google Scholar
Kaur M., Singh P., Singh K., Gaharwar U.S., Meena R., Kumar M., Nakagawa F., Wu S., Suzuki M., Nakamura H., Kumar A.: Boron nitride (10BN) a prospective material for treatment of cancer by boron neutron capture therapy (BNCT). Mater. Lett., 2020; 259: 126832KaurM.SinghP.SinghK.GaharwarU.S.MeenaR.KumarM.NakagawaF.WuS.SuzukiM.NakamuraH.KumarA.Boron nitride (10BN) a prospective material for treatment of cancer by boron neutron capture therapy (BNCT)202025912683210.1016/j.matlet.2019.126832Search in Google Scholar
Kawabata S., Yang W., Barth R.F., Wu G., Huo T., Binns P.J., Riley K.J., Ongayi O., Gottumukkala V., Vicente M.G.: Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors. J. Neuro-Oncol., 2011; 103: 175–185KawabataS.YangW.BarthR.F.WuG.HuoT.BinnsP.J.RileyK.J.OngayiO.GottumukkalaV.VicenteM.G.Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors201110317518510.1007/s11060-010-0376-5300508120848301Search in Google Scholar
Kimura Y., Ariyoshi Y., Shimahara M., Miyatake S., Kawabata S., Ono K., Suzuki M., Maruhashi A.: Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node. Appl. Radiat. Isot., 2009; 67: S47–S49KimuraY.AriyoshiY.ShimaharaM.MiyatakeS.KawabataS.OnoK.SuzukiM.MaruhashiA.Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node200967S47S4910.1016/j.apradiso.2009.03.01919395269Search in Google Scholar
Kiyanagi Y., Sakurai Y., Kumada H., Tanaka H.: Status of accelerator-based BNCT projects worldwide. AIP Conf. Proc., 2019; 2160: 050012KiyanagiY.SakuraiY.KumadaH.TanakaH.Status of accelerator-based BNCT projects worldwide2019216005001210.1063/1.5127704Search in Google Scholar
Kullberg E.B., Wei Q., Capala J., Giusti V., Malmström P.U., Gedda L.: EGF-receptor targeted liposomes with boronatedacridine: Growth inhibition of cultured glioma cells after neutron irradiation. Int. J. Radiat. Biol., 2005; 81: 621–629KullbergE.B.WeiQ.CapalaJ.GiustiV.MalmströmP.U.GeddaL.EGF-receptor targeted liposomes with boronatedacridine: Growth inhibition of cultured glioma cells after neutron irradiation20058162162910.1080/0955300050033213716298943Search in Google Scholar
Kumada H., Naito F., Hasegawa K., Kobayashi H., Kurihara T., Takada K., Onishi T., Sakurai H., Matsumura A., Sakae T.: Development of LINAC-based neutron source for Boron Neutron Capture Therapy in University of Tsukuba. Plasma Fusion Res., 2018; 13: 2406006KumadaH.NaitoF.HasegawaK.KobayashiH.KuriharaT.TakadaK.OnishiT.SakuraiH.MatsumuraA.SakaeT.Development of LINAC-based neutron source for Boron Neutron Capture Therapy in University of Tsukuba201813240600610.1585/pfr.13.2406006Search in Google Scholar
Lai C.H., Lin Y.C., Chou F.I., Liang C.F., Lin E.W., Chuang Y.J., Lin C.C.: Design of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy. Chem. Commun., 2012; 48: 612–614LaiC.H.LinY.C.ChouF.I.LiangC.F.LinE.W.ChuangY.J.LinC.C.Design of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy20124861261410.1039/C1CC14447BSearch in Google Scholar
Lam C.W., James J.T., McCluskey R., Hunter R.L.: Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci., 2004; 77: 126–134LamC.W.JamesJ.T.McCluskeyR.HunterR.L.Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation20047712613410.1093/toxsci/kfg24314514958Search in Google Scholar
Lee C.H., Zhang D., Yap Y.K.: Functionalization, dispersion, and cutting of boron nitride nanotubes in water. J. Phys. Chem. C, 2012; 116: 1798–1804LeeC.H.ZhangD.YapY.K.Functionalization, dispersion, and cutting of boron nitride nanotubes in water20121161798180410.1021/jp2112999Search in Google Scholar
Luderer M.J., de la Puente P., Azab A.K.: Advancements in tumor targeting strategies for Boron Neutron Capture Therapy. Pharm. Res., 2015; 32: 2824–2836LudererM.J.de la PuenteP.AzabA.K.Advancements in tumor targeting strategies for Boron Neutron Capture Therapy2015322824283610.1007/s11095-015-1718-ySearch in Google Scholar
Luderer M.J., Muz B., Alhallak K., Sun J., Wasden K., Guenthner N., de la Puente P., Federico C., Azab A.K.: Thermal sensitive liposomes improve delivery of boronated agents for Boron Neutron Capture Therapy. Pharm. Res., 2019; 36: 144LudererM.J.MuzB.AlhallakK.SunJ.WasdenK.GuenthnerN.de la PuenteP.FedericoC.AzabA.K.Thermal sensitive liposomes improve delivery of boronated agents for Boron Neutron Capture Therapy20193614410.1007/s11095-019-2670-zSearch in Google Scholar
Masunaga S., Kasaoka S., Maruyama K., Nigg D., Sakurai Y., Nagata K., Suzuki M., Kinashi Y., Maruhashi A., Ono K.: The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-10B (GB-10) as 10B-carriers for boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys., 2006; 66: 1515–1522MasunagaS.KasaokaS.MaruyamaK.NiggD.SakuraiY.NagataK.SuzukiM.KinashiY.MaruhashiA.OnoK.The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-10B (GB-10) as 10B-carriers for boron neutron capture therapy2006661515152210.1016/j.ijrobp.2006.08.028Search in Google Scholar
Mattson M.P., Haddon R.C., Rao A.M.: Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth. J. Mol. Neurosci., 2000; 14: 175–182MattsonM.P.HaddonR.C.RaoA.M.Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth20001417518210.1385/JMN:14:3:175Search in Google Scholar
Mi P., Yanagie H., Dewi N., Yen H.C., Liu X., Suzuki M., Sakurai Y., Ono K., Takahashi H., Cabral H., Kataoka K., Nishiyama N.: Block co-polymer boron cluster conjugate for effective boron neutron capture therapy of solid tumors. J. Control. Release, 2017; 254: 1–9MiP.YanagieH.DewiN.YenH.C.LiuX.SuzukiM.SakuraiY.OnoK.TakahashiH.CabralH.KataokaK.NishiyamaN.Block co-polymer boron cluster conjugate for effective boron neutron capture therapy of solid tumors20172541910.1016/j.jconrel.2017.03.036Search in Google Scholar
Michiue H., Sakurai Y., Kondo N., Kitamatsu M., Bin F., Nakajima K., Hirota Y., Kawabata S., Nishiki T., Ohmori I., Tomizawa K., Miyatake S., Ono K., Matsui H.: The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide. Biomaterials, 2014; 35: 3396–3405MichiueH.SakuraiY.KondoN.KitamatsuM.BinF.NakajimaK.HirotaY.KawabataS.NishikiT.OhmoriI.TomizawaK.MiyatakeS.OnoK.MatsuiH.The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide2014353396340510.1016/j.biomaterials.2013.12.055Search in Google Scholar
Mirzaei H.R., Sahebkar A., Salehi R., Nahand J.S., Karimi E., Jaafari M.R., Mirzaei H.: Boron neutron capture therapy: Moving toward targeted cancer therapy. J. Cancer Res. Ther., 2016; 12: 520–525MirzaeiH.R.SahebkarA.SalehiR.NahandJ.S.KarimiE.JaafariM.R.MirzaeiH.Boron neutron capture therapy: Moving toward targeted cancer therapy20161252052510.4103/0973-1482.176167Search in Google Scholar
Mishima Y., Honda C., Ichihashi M., Obara H., Hiratsuka J., Fukuda H., Karashima H., Kobayashi T., Kanda K., Yoshino K.: Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet, 1989; 2: 388–389MishimaY.HondaC.IchihashiM.ObaraH.HiratsukaJ.FukudaH.KarashimaH.KobayashiT.KandaK.YoshinoK.Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound1989238838910.1016/S0140-6736(89)90567-9Search in Google Scholar
Miyatake S.I., Kawabata S., Hiramatsu R., Kuroiwa T., Suzuki M., Ono K.: Boron Neutron Capture Therapy of malignant gliomas. Prog. Neurol. Surg., 2018; 32: 48–56MiyatakeS.I.KawabataS.HiramatsuR.KuroiwaT.SuzukiM.OnoK.Boron Neutron Capture Therapy of malignant gliomas201832485610.1159/000469679Search in Google Scholar
Miyatake S.I., Kawabata S., Kajimoto Y., Aoki A., Yokoyama K., Yamada M., Kuroiwa T., Tsuji M., Imahori Y., Kirihata M., Sakurai Y., Masunaga S.I., Nagata K., Maruhashi A., Ono K.: Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: An efficacy study based on findings on neuroimages. J. Neurosurg., 2005; 103: 1000–1009MiyatakeS.I.KawabataS.KajimotoY.AokiA.YokoyamaK.YamadaM.KuroiwaT.TsujiM.ImahoriY.KirihataM.SakuraiY.MasunagaS.I.NagataK.MaruhashiA.OnoK.Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: An efficacy study based on findings on neuroimages20051031000100910.3171/jns.2005.103.6.100016381186Search in Google Scholar
Mortensen M.W., Sørensen P.G., Björkdahl O., Jensen M.R., Gundersen H.J., Bjørnholm T.: Preparation and characterization of boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapy. Appl. Radiat. Isot., 2006; 64: 315–324MortensenM.W.SørensenP.G.BjörkdahlO.JensenM.R.GundersenH.J.BjørnholmT.Preparation and characterization of boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapy20066431532410.1016/j.apradiso.2005.08.00316290943Search in Google Scholar
Moss R.L.: Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT). Appl. Radiat. Isot., 2014; 88: 2–11MossR.L.Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT)20148821110.1016/j.apradiso.2013.11.10924355301Search in Google Scholar
Naito F.: Introduction to accelerators for boron neutron capture therapy. Ther. Radiol. Oncol., 2018; 2: 54NaitoF.Introduction to accelerators for boron neutron capture therapy201825410.21037/tro.2018.10.11Search in Google Scholar
Nakagawa Y., Pooh K., Kobayashi T., Kageji T., Uyama S., Matsumura A., Kumada H.: Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams. J. Neuro-Oncol., 2003; 62: 87–99NakagawaY.PoohK.KobayashiT.KagejiT.UyamaS.MatsumuraA.KumadaH.Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams200362879910.1007/BF0269993612749705Search in Google Scholar
Nakamura H., Koganei H., Miyoshi T., Sakurai Y., Ono K., Suzuki M.: Antitumor effect of boron nitride nanotubes in combination with thermal neutron irradiation on BNCT. Bioorg. Med. Chem. Lett., 2015; 25: 172–174NakamuraH.KoganeiH.MiyoshiT.SakuraiY.OnoK.SuzukiM.Antitumor effect of boron nitride nanotubes in combination with thermal neutron irradiation on BNCT20152517217410.1016/j.bmcl.2014.12.00525522821Search in Google Scholar
Nakamura S., Imamichi S., Masumoto K., Ito M., Wakita A., Okamoto H., Nishioka S., Iijima K., Kobayashi K., Abe Y., Igaki H., Kurita K., Nishio T., Masutani M., Itami J.: Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy system. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci., 2017; 93: 821–831NakamuraS.ImamichiS.MasumotoK.ItoM.WakitaA.OkamotoH.NishiokaS.IijimaK.KobayashiK.AbeY.IgakiH.KuritaK.NishioT.MasutaniM.ItamiJ.Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy system20179382183110.2183/pjab.93.051579075929225308Search in Google Scholar
Nedunchezhian K., Aswath N., Thiruppathy M., Thirugnanamurthy S.: Boron Neutron Capture Therapy – A literature review. J. Clin. Diagn. Res., 2016; 10: ZE01–ZE04NedunchezhianK.AswathN.ThiruppathyM.ThirugnanamurthyS.Boron Neutron Capture Therapy – A literature review201610ZE01ZE0410.7860/JCDR/2016/19890.9024529658828209015Search in Google Scholar
Nemoto H., Cai J., Asao N., Iwamoto S., Yamamoto Y.: Synthesis and biological properties of water-soluble p-boronophenylalanine derivatives. Relationship between water solubility, cytotoxicity, and cellular uptake. J. Med. Chem., 1995; 38: 1673–1678NemotoH.CaiJ.AsaoN.IwamotoS.YamamotoY.Synthesis and biological properties of water-soluble p-boronophenylalanine derivatives. Relationship between water solubility, cytotoxicity, and cellular uptake1995381673167810.1021/jm00010a0127752191Search in Google Scholar
Petersen M.S., Petersen C.C., Agger R., Sutmuller M., Jensen M.R., Sørensen P.G., Mortensen M.W., Hansen T., Bjørnholm T., Gundersen H.J., Huiskamp R., Hokland M.: Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model. Anticancer Res., 2008; 28: 571–576PetersenM.S.PetersenC.C.AggerR.SutmullerM.JensenM.R.SørensenP.G.MortensenM.W.HansenT.BjørnholmT.GundersenH.J.HuiskampR.HoklandM.Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model200828571576Search in Google Scholar
Radomski J., Rećko W.M., Ketling-Szemley M.: Własności azotku boru i metody jego otrzymywania. Wydawnictwa Przemysłu Maszynowego “WEMA”. Warszawa 1980RadomskiJ.RećkoW.M.Ketling-SzemleyM.Wydawnictwa Przemysłu Maszynowego “WEMA”Warszawa1980Search in Google Scholar
Ryashentsev D.S., Belenkov E.A.: New BN polymorphs with two-dimensional structure. IOP Conf. Ser.: Mater. Sci. Eng., 2019; 537: 022060RyashentsevD.S.BelenkovE.A.New BN polymorphs with two-dimensional structure201953702206010.1088/1757-899X/537/2/022060Search in Google Scholar
Seki R., Wakisaka Y., Morimoto N., Takashina M., Koizumi M., Toki H., Fukuda M.: Physics of epi-thermal boron neutron capture therapy (epi-thermal BNCT). Radiol. Phys. Technol., 2017; 10: 387–408SekiR.WakisakaY.MorimotoN.TakashinaM.KoizumiM.TokiH.FukudaM.Physics of epi-thermal boron neutron capture therapy (epi-thermal BNCT)20171038740810.1007/s12194-017-0430-529159536Search in Google Scholar
Şen Ö., Emanet M., Çulha M.: One-step synthesis of hexagonal boron nitrides, their crystallinity and biodegradation. Front. Bioeng. Biotechnol., 2018; 6: 83ŞenÖ.EmanetM.ÇulhaM.One-step synthesis of hexagonal boron nitrides, their crystallinity and biodegradation201868310.3389/fbioe.2018.00083602149929977891Search in Google Scholar
Shvedova A.A., Castranova V., Kisin E.R., Schwegler-Berry D., Murray A.R., Gandelsman V.Z., Maynard A., Baron P.: Exposure to carbon nanotube material: Assessment of nanotube cytotoxicity using human keratinocyte cells. J. Toxicol. Environ. Health A, 2003; 66: 1909–1926ShvedovaA.A.CastranovaV.KisinE.R.Schwegler-BerryD.MurrayA.R.GandelsmanV.Z.MaynardA.BaronP.Exposure to carbon nanotube material: Assessment of nanotube cytotoxicity using human keratinocyte cells2003661909192610.1080/71385395614514433Search in Google Scholar
Singh B., Kaur G., Singh P., Singh K. Kumar B., Vij A., Kumar M., Bala R., Meena R., Singh A., Thakur A., Kumar A.: Nanostructured boron nitride with high water dispersibility for Boron Neutron Capture Therapy. Sci. Rep., 2016; 6: 35535SinghB.KaurG.SinghP.SinghK.KumarB.VijA.KumarM.BalaR.MeenaR.SinghA.ThakurA.KumarA.Nanostructured boron nitride with high water dispersibility for Boron Neutron Capture Therapy201663553510.1038/srep35535506968727759052Search in Google Scholar
Slatkin D.N.: A history of boron neutron capture therapy of brain tumours. Postulation of a brain radiation dose tolerance limit. Brain, 1991; 114: 1609–1629SlatkinD.N.A history of boron neutron capture therapy of brain tumours. Postulation of a brain radiation dose tolerance limit19911141609162910.1093/brain/114.4.16091884169Search in Google Scholar
Suzuki M.: Boron neutron capture therapy (BNCT): A unique role in radiotherapy with a view to entering the accelerator-based BNCT era. Int. J. Clin. Oncol., 2020; 25: 43–50SuzukiM.Boron neutron capture therapy (BNCT): A unique role in radiotherapy with a view to entering the accelerator-based BNCT era202025435010.1007/s10147-019-01480-431168726Search in Google Scholar
Suzuki M., Masunaga S.I., Kinashi Y., Takagaki M., Sakurai Y., Kobayashi T., Ono K.: The effects of boron neutron capture therapy on liver tumors and normal hepatocytes in mice. Jpn. J. Cancer Res., 2000; 91: 1058–1064SuzukiM.MasunagaS.I.KinashiY.TakagakiM.SakuraiY.KobayashiT.OnoK.The effects of boron neutron capture therapy on liver tumors and normal hepatocytes in mice2000911058106410.1111/j.1349-7006.2000.tb00885.x592626811050478Search in Google Scholar
Tajes M., Ramos-Fernández E., Weng-Jiang X., Bosch-Morató M., Guivernau B., Eraso-Pichot A., Salvador B., Fernàndez-Busquets X., Roquer J., Muñoz F.J.: The blood-brain barrier: Structure, function and therapeutic approaches to cross it. Mol. Membr. Biol., 2014; 31: 152–167TajesM.Ramos-FernándezE.Weng-JiangX.Bosch-MoratóM.GuivernauB.Eraso-PichotA.SalvadorB.Fernàndez-BusquetsX.RoquerJ.MuñozF.J.The blood-brain barrier: Structure, function and therapeutic approaches to cross it20143115216710.3109/09687688.2014.93746825046533Search in Google Scholar
Tsuji T., Yoshitomi H., Ishikawa Y., Koshizaki N., Suzuki M., Usukura J.: A method to selectively internalize submicrometer boron carbide particles into cancer cells using surface transferrin conjugation for developing a new boron neutron capture therapy agent. J. Exp. Nanosci., 2020; 15: 1–11TsujiT.YoshitomiH.IshikawaY.KoshizakiN.SuzukiM.UsukuraJ.A method to selectively internalize submicrometer boron carbide particles into cancer cells using surface transferrin conjugation for developing a new boron neutron capture therapy agent20201511110.1080/17458080.2019.1692178Search in Google Scholar
Türkez H., Arslan M.E., Sönmez E., Geyikoğlu F., Açıkyıldız M., Tatar A.: Microarray assisted toxicological investigations of boron carbide nanoparticles on human primary alveolar epithelial cells. Chem. Biol. Interact., 2019; 300: 131–137TürkezH.ArslanM.E.SönmezE.GeyikoğluF.AçıkyıldızM.TatarA.Microarray assisted toxicological investigations of boron carbide nanoparticles on human primary alveolar epithelial cells201930013113710.1016/j.cbi.2019.01.02130684454Search in Google Scholar
Vos M.J., Turowski B., Zanella F.E., Paquis P., Siefert A., Hideghéty K., Haselsberger K., Grochulla F., Postma T.J., Wittig A., Heimans J.J., Slotman B.J., Vandertop W.P., Sauerwein W.: Radiologic findings in patients treated with boron neutron capture therapy for glioblastoma multiforme within EORTC trial 11961. Int. J. Radiat. Oncol. Biol. Phys., 2005; 61: 392–399VosM.J.TurowskiB.ZanellaF.E.PaquisP.SiefertA.HideghétyK.HaselsbergerK.GrochullaF.PostmaT.J.WittigA.HeimansJ.J.SlotmanB.J.VandertopW.P.SauerweinW.Radiologic findings in patients treated with boron neutron capture therapy for glioblastoma multiforme within EORTC trial 1196120056139239910.1016/j.ijrobp.2004.06.008Search in Google Scholar
Warheit D.B., Laurence B.R., Reed K.L., Roach D.H., Reynolds G.A., Webb T.R.: Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci., 2004; 77: 117–125WarheitD.B.LaurenceB.R.ReedK.L.RoachD.H.ReynoldsG.A.WebbT.R.Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats20047711712510.1093/toxsci/kfg228Search in Google Scholar
Weng Q., Wang B., Wang X., Hanagata N., Li X., Liu D., Wang X., Jiang X., Bando Y., Golberg D.: Highly water-soluble, porous, and biocompatible boron nitrides for anticancer drug delivery. ACS Nano, 2014; 8: 6123–6130WengQ.WangB.WangX.HanagataN.LiX.LiuD.WangX.JiangX.BandoY.GolbergD.Highly water-soluble, porous, and biocompatible boron nitrides for anticancer drug delivery201486123613010.1021/nn5014808Search in Google Scholar
Wittig A., Sauerwein W.A., Coderre J.A.: Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro. Radiat. Res., 2000; 153: 173–180WittigA.SauerweinW.A.CoderreJ.A.Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro200015317318010.1667/0033-7587(2000)153[0173:MOTOPB]2.0.CO;2Search in Google Scholar
Wittig A., Stecher-Rasmussen F., Hilger R.A., Rassow J., Mauri P., Sauerwein W.: Sodium mercaptoundecahydro-closo-dodecaborate (BSH), a boron carrier that merits more attention. Appl. Radiat. Isot., 2011; 69: 1760–1764WittigA.Stecher-RasmussenF.HilgerR.A.RassowJ.MauriP.SauerweinW.Sodium mercaptoundecahydro-closo-dodecaborate (BSH), a boron carrier that merits more attention2011691760176410.1016/j.apradiso.2011.02.046Search in Google Scholar
Wu G., Yang W., Barth R.F., Kawabata S., Swindall M., Bandyopadhyaya A.K., Tjarks W., Khorsandi B., Blue T.E., Ferketich A.K., Yang M., Christoforidis G.A., Sferra T.J., Binns P.J., Riley K.J. i wsp.: Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab. Clin. Cancer Res., 2007; 13: 1260–1268WuG.YangW.BarthR.F.KawabataS.SwindallM.BandyopadhyayaA.K.TjarksW.KhorsandiB.BlueT.E.FerketichA.K.YangM.ChristoforidisG.A.SferraT.J.BinnsP.J.RileyK.J.i wsp.Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab2007131260126810.1158/1078-0432.CCR-06-2399Search in Google Scholar
Yanagië H., Tomita T., Kobayashi H., Fujii Y., Takahashi T., Hasumi K., Nariuchi H., Sekiguchi M.: Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model. Br. J. Cancer, 1991; 63: 522–526YanagiëH.TomitaT.KobayashiH.FujiiY.TakahashiT.HasumiK.NariuchiH.SekiguchiM.Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model19916352252610.1038/bjc.1991.124Search in Google Scholar
Yang W., Barth R.F., Wu G., Tjarks W., Binns P., Riley K.: Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents. Appl. Radiat. Isot., 2009; 67: S328–S331YangW.BarthR.F.WuG.TjarksW.BinnsP.RileyK.Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents200967S328S33110.1016/j.apradiso.2009.03.030Search in Google Scholar
Yang W., Wu G., Barth R.F., Swindall M.R., Bandyopadhyaya A.K., Tjarks W., Tordoff K., Moeschberger M., Sferra T.J., Binns P.J., Riley K.J., Ciesielski M.J., Fenstermaker R.A., Wikstrand C.J.: Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies. Clin. Cancer Res., 2008; 14: 883–891YangW.WuG.BarthR.F.SwindallM.R.BandyopadhyayaA.K.TjarksW.TordoffK.MoeschbergerM.SferraT.J.BinnsP.J.RileyK.J.CiesielskiM.J.FenstermakerR.A.WikstrandC.J.Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies20081488389110.1158/1078-0432.CCR-07-1968Search in Google Scholar
Yinghuai Z., Peng A.T., Carpenter K., Maguire J.A., Hosmane N.S., Takagaki M.: Substituted carborane-appended water-soluble single-wall carbon nanotubes: New approach to Boron Neutron Capture Therapy drug delivery. J. Am. Chem. Soc., 2005; 127: 9875–9880YinghuaiZ.PengA.T.CarpenterK.MaguireJ.A.HosmaneN.S.TakagakiM.Substituted carborane-appended water-soluble single-wall carbon nanotubes: New approach to Boron Neutron Capture Therapy drug delivery20051279875988010.1021/ja0517116Search in Google Scholar
Yokoyama K., Miyatake S., Kajimoto Y., Kawabata S., Doi A., Yoshida T., Asano T., Kirihata M., Ono K., Kuroiwa T.: Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT. J. Neuro-Oncol., 2006; 78: 227–232YokoyamaK.MiyatakeS.KajimotoY.KawabataS.DoiA.YoshidaT.AsanoT.KirihataM.OnoK.KuroiwaT.Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT20067822723210.1007/s11060-005-9099-416557351Search in Google Scholar
Zhuo J.C., Cai J., Soloway A.H., Barth R.F., Adams D.M., Ji W., Tjarks W.: Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron capture therapy of brain tumors. J. Med. Chem., 1999; 42: 1282–1292ZhuoJ.C.CaiJ.SolowayA.H.BarthR.F.AdamsD.M.JiW.TjarksW.Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron capture therapy of brain tumors1999421282129210.1021/jm980703f10197971Search in Google Scholar